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Background/Introduction
Bleeding complications and perioperative cardiovascular
events are strongly influenced by the management of
antithrombotic therapy before and after Coronary Artery
Bypass Grafting (CABG). Early thrombosis is a major
cause of vein graft attrition after CABG1 with occlusion
rates ranging between 5 - 26% 2. There is scarce evidence
in dual antiplatelet therapy post elective CABG.
Aims/Objectives
The primary objective of this survey was to establish the
variations in antiplatelet therapy post CABG in all cardi-
othoracic units across the United Kingdom (UK).
Method
A comprehensive list of all cardiothoracic units across the
UK was obtained from the Society for Cardiothoracic Sur-
gery (SCTS). 41 units were identified in England, Scotland,
Wales and Northern Ireland. Questionnaire regarding
antiplatelet therapy was developed and administered to
the on call cardiothoracic registrars over a 3 day period.
Data was analysed using Microsoft Excel.
Results
All 41 centres responded to the questionnaire. 300 mg
Aspirin (ASA) was given Per Rectum 6 hours post CABG
in 66% of the units while surgeon specific variation existed
in 24% of the units and it was not given in 10% of the
units. Post elective CABG, 51% of the units gave isolated
ASA 75 mg for life while variation between consultants
within the unit existed in 27%, dual antiplatelet therapy
was used in 10% and varying doses of ASA administered
in 7%. In post CABG patients with previous Coronary
Stents or recent Acute Coronary Syndromes 51% of the
units added 75 mg of Clopidogrel, 5% added ticagrelor
(180 mg loading then 90 mg twice daily) to ASA while 2%
only gave Aspirin with variable practice between surgeons
within the same unit in 37% of the units. Variation in
practice existed in 85% of the units in this survey.
Discussion/Conclusion
This survey highlights a diverse practice in antiplatelet
therapy between cardiothoracic units across the UK.
There is also variation in practice between the consultants
within each unit. Comprehensive survey of individual
cardiothoracic surgeons across the UK may highlight.
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